As a SMAD2-specific interaction protein, CCT6A acts as an inhibitor of SMAD2 in NSCLC, thereby promoting TGF-β1-mediated NSCLC transfer (Ying et al., 2017). This evidence concerns the gene CCT6A and non-small cell lung carcinoma.